• LAST PRICE
    1.2100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    1.2100 / 1.2100
  • Day Range
    Low 1.2100
    High 1.2100
  • 52 Week Range
    Low 1.0100
    High 3.2500
  • Volume
    190
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 1.21
TimeVolumeMRZM
03:24 ET1301.21
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMRZM
Marizyme Inc
49.0M
-2.4x
---
United StatesRPHM
Reneo Pharmaceuticals Inc
49.5M
-1.0x
---
United StatesMBIO
Mustang Bio Inc
49.6M
-0.5x
---
United StatesCYT
Cyteir Therapeutics Inc
48.2M
-1.0x
---
United StatesGRTX
Galera Therapeutics Inc
47.6M
-0.7x
---
United StatesIMNM
Immunome Inc
50.9M
-1.3x
---
As of 2022-12-06

Company Information

Marizyme, Inc. is a multi-technology life science company. The Company is engaged in the research, manufacture and commercialization of medical devices, diagnostics and products to address unmet clinical needs. Its products include DuraGraft, MATLOC 1 and Krillase. DuraGraft is a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, thereby reducing the incidence and complications of graft failure and improving clinical outcomes post bypass surgery. MATLOC is a lab-on-chip digital screening and diagnostic device platform, which is being developed for quantitative chronic kidney disease (CKD) assessment. Krillase can be used in the treatment of chronic wounds and burns, and other clinical applications. Its DuraGraft is an endothelial damage inhibitor (EDI), indicated for cardiac bypass, peripheral bypass, and other vascular surgeries.

Contact Information

Headquarters
555 HERITAGE DRIVE, SUITE 205JUPITER, FL, United States 33458
Phone
561-935-9955
Fax
770-720-1335

Executives

Chairman of the Board
Vithalbhai Dhaduk
Chief Executive Officer, Director
David Barthel
Chief Financial Officer
George Kovalyov
Executive Vice President - Medical and Regulatory Affairs, Chief Medical Officer
Steven Brooks
Executive Vice President - Regulatory & Quality Affairs
Amy Chandler

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$49.0M
Revenue (TTM)
$76.1K
Shares Outstanding
40.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.75
EPS
$-0.51
Book Value
$1.18
P/E Ratio
-2.4x
Price/Sales (TTM)
644.1
Price/Cash Flow (TTM)
---
Operating Margin
-18,958.06%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.